- $1.12bn
- $887.13m
- $550.67m
- 71
- 65
- 100
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 243 | 273 | 408 | 500 | 551 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 194 | 262 | 390 | 560 | 422 |
Operating Profit | 49.1 | 11.7 | 17.6 | -60.6 | 129 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 36.1 | 36.9 | 11.2 | -68.4 | 118 |
Provision for Income Taxes | |||||
Net Income After Taxes | 26.6 | 27.6 | 7.24 | -54.6 | 89.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26.6 | 27.6 | 1.86 | -58.5 | 79 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 33.9 | 33.8 | 1.83 | -55 | 76.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.33 | 0.66 | 0.215 | -6.08 | 6.92 |
Dividends per Share |